St Jude's vascular closure device gets FDA approval:
This article was originally published in Clinica
Executive Summary
St Jude Medical has received US FDA approval to market its 6F Angio-Seal vascular closure device, used to seal arterial punctures created during interventional cardiology procedures. The device includes new enhancement techniques that further simplify deployment, eliminating the need to dilate the arterial puncture site. Angio-Seal devices have successfully penetrated the European market and are expected to have a strong impact in the US, said the St Paul, Minneapolis-based company.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.